Issue Navigation
-
Original Article
-
83-89
Silkworm (Bombyx mori) as a novel infection model for fish-derived Aeromonas hydrophila
Miyashita A, Mikami K, Nakajima H, Yu Y, Miyauchi M, Sekimizu K
Drug Discov Ther. 2025; 19(2):83-89.
DOI: 10.5582/ddt.2025.01026
-
90-95
Practical training reduces aspiration-linked gaps in pressure ulcer education for pharmacy students
Kondo S, Mima R, Okui R, Iwata H, Kawamoto Y, Kobayashi N, Furuta K, Yamaura K
Drug Discov Ther. 2025; 19(2):90-95.
DOI: 10.5582/ddt.2025.01025
-
96-102
Yokoyama S, Kozai H, Kikuchi A, Ota S, Horibe T, Tanaka M
Drug Discov Ther. 2025; 19(2):96-102.
DOI: 10.5582/ddt.2025.01013
-
103-111
Yu YD, Li Y, Li JY, Zhang X, Hu PZ, Chen XM, Huang WJ, Wen C, Deng L, Cheng XH, Yu N, Huang LH
Drug Discov Ther. 2025; 19(2):103-111.
DOI: 10.5582/ddt.2025.01023
-
112-123
Zhang X, Guan HJ, Di XY, Li MQ, Peng JL, Cai RT, Wei HX
Drug Discov Ther. 2025; 19(2):112-123.
DOI: 10.5582/ddt.2025.01011
-
124-128
Can the herpes zoster vaccination be a strategy against dementia?
Ma YN, Karako K, Song PP, Xia Y
Drug Discov Ther. 2025; 19(2):124-128.
DOI: 10.5582/ddt.2025.01032
-
129-130
Hu SS, Yu HZ, Gao JJ
Drug Discov Ther. 2025; 19(2):129-130.
DOI: 10.5582/ddt.2025.01028
-
131-132
Fitusiran: The first approved siRNA therapy for hemophilia via reducing plasma antithrombin levels
Lu DR, Dou FZ, Gao JJ
Drug Discov Ther. 2025; 19(2):131-132.
DOI: 10.5582/ddt.2025.01031
-
133-135
Effects of patient age on the therapeutic effects of GIP/GLP-1 receptor agonists (tirzepatide)
Ishimura A, Shimizu Y, Yabuki N
Drug Discov Ther. 2025; 19(2):133-135.
DOI: 10.5582/ddt.2025.01012